期刊文献+

靶向干扰细胞周期检验点激酶2增强5-氟尿嘧啶对鼻咽癌细胞SUNE-1的毒性作用研究

Enhanced sensitivity of nasopharyngeal carcinoma SUNE-1 cells to 5-FU by Chk2 knockdown
下载PDF
导出
摘要 目的探讨靶向抑制细胞周期检验点激酶2(Chk2)对5-氟尿嘧啶(5-FU)抗鼻咽癌鳞状上皮细胞SUNE-1的增敏作用。方法根据Chk2基因设计siRNA干扰序列,在mRNA和蛋白水平检测其干扰效果;通过细胞生长曲线观察Chk2siRNA对SUNE-1细胞增殖能力的影响;通过细胞毒性试验检测Chk2siRNA是否影响SUNE-1细胞对代谢类抗肿瘤药5-FU的敏感性;采用AnnexinV/PI双染方法检测细胞凋亡的变化情况。结果所采用的siRNA在mRNA和蛋白水平均显著降低SUNE-1细胞中Chk2表达,验证了该siRNA的干扰效果;Chk2siRNA对SUNE-1细胞增殖能力无显著影响,但能显著增强5-Fu的细胞毒作用(P〈0.05);细胞凋亡检测结果显示,Chk2siRNA显著增加5-FU引起的SUNE-1细胞凋亡水平。结论尽管Chk2对SUNE-1细胞生存和增殖不发挥关键作用,但在5-Fu引起的细胞损伤中对细胞起保护作用,该作用与其抑制5-FU引起的细胞凋亡有关,因此Chk2可成为在鼻咽癌治疗中增强5-FU的疗效的靶点。 Objective To investigate the chemosensitization of Chk2 inhibition to 5-FU against nasopharyngeal squamous epithelial cell line SUNE-1. Methods Chk2 siRNA was designed according to the mRNA sequence of Chk2, and its effect was confirmed by RT-PCR and Western blotting in SUNE-1 cells. Cell growth assay was evaluated to determine the impact of Chk2 siRNA on the proliferation ability of SUNE-1 cells and MTT assay was used to determine the chemosensitization of Chk2 siRNA to 5-FU. Finally, apoptotic cells was stained with Annexin V/PI and examined by flow cytometry. Results Chk2 siRNA significantly reduced mRNA and protein levels of Chk2 in SUNE-1 cells, which confirmed the knockdown effect of Chk2 siRNA. Cell growth assay showed that Chk2 siRNA did not influence the proliferation of SUNE-1 cells. However, Chk2 knockdown significantly enhanced the cytotoxicity and apoptosis of SUNE-1 cells caused by 5-FU. Conclusion Chk2 hinders the toxic effect of 5-FU on SUNE-1 cells, which can be enhanced by Chk2 inhibition. Therefore, Chk2 can be proposed as a target to increase the effect of chemotherapeutic agent, such as 5-FU, in clinical treatment on nasopharyngeal carcinoma.
出处 《中华老年多器官疾病杂志》 2012年第3期213-216,共4页 Chinese Journal of Multiple Organ Diseases in the Elderly
基金 国家自然科学基金(81000835,81000011) 广东省自然科学基金(10451018201004913)
关键词 抗肿瘤药 鼻咽癌 5-氟尿嘧啶 细胞周期检验点激酶 RNA干扰 antineoplasitc agents nasopharyngeal carcinoma 5-FU Chk2 RNA interference
  • 相关文献

参考文献18

  • 1Hurley LH. DNA and its associated processes as targets for cancer therapy[J]. Nat Rev Cancer, 2002, 2(3): 188-200.
  • 2Kohn KW, Jackman J, O'Connor PM. Cell cycle control and cancer chemotherapy[J]. J Cell Biochem, 1994, 54(4): 440-452.
  • 3Hartwell LH, Kastan MB. Cell cycle control and cancer[J]. Science, 1994, 266(5192): 1821-1828.
  • 4Kastan MB, Bartek J. Cell-cycle checkpoints and cancer[J]. Nature, 2004, 432(7015): 316-323.
  • 5Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective[J]. Nature, 2000, 408(6811): 433-439.
  • 6潘宇,邵荣光.靶向细胞周期检验点的肿瘤治疗[J].解放军医学杂志,2008,33(11):1387-1388. 被引量:1
  • 7Pan Y, Ren KH, He HW, et al. Knockdown of Chkl sensitizes human colon carcinoma HCTll6 ceils in a p53-dependent manner to hdamycin through abrogation of a G2/M checkpoint and induction of apoptosis[J]. Cancer Biol Ther, 2009, 8(16): 1559-1566.
  • 8Helleday T, Petermann E, Lundin C, et al. DNA repair pathways as targets for cancer therapy[J]. Nat Rev Cancer, 2008, 8(3): 193-204.
  • 9Ashwell S, Zabludoff S. DNA damage detection and repair pathways--recent advances with inhibitors of checkpoint kinases in cancer therapy[J]. Clin Cancer Res, 2008, 14(13): 4032-4037.
  • 10Mukhopadhyay UK, Senderowicz AM, Ferbeyre G. RNA silencing of checkpoint regulators sensitizes p53-defective prostate cancer cells to chemotherapy while sparing normal cells[J]. Cancer Res, 2005, 65(7): 2872-2881.

二级参考文献19

  • 1邵荣光.以细胞周期调控分子为靶点的肿瘤治疗[J].中国肿瘤,2005,14(11):706-708. 被引量:11
  • 2Arienti KL, Brunmark A, Axe FU, et al. Checkpoint kinase inhibitors: SAR and radioproteetive properties of a series of 2-arylbenzimidazoles. J Med Chem, 2005, 48(6):1873.
  • 3Matthews DJ, Yakes FM, Chen J, et aL Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine invivo. Cell Cycle, 2007, 6(1):104.
  • 4Bartkova J, Rezaei N, Liontos M, et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature, 2006, 444(7119):633.
  • 5Di Micco R, Fumagalli M, Cicalese A,et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature, 2006, 444(7119):638.
  • 6DiTullio RA Jr, Mochan TA, Venere M, et al. 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer. Nat Cell Biol, 2002, 4(12):998.
  • 7Halazonetis TD, Gorgoulis VG, Bartek J. An onoongen-induced DNA damage model for cancer development. Science, 2008, 319(5868):1352.
  • 8Gorgoulis VG, Vassiliou LV, Karakaidos P, et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature, 2005, 434(7035) :907.
  • 9Bartkova J, Horejsi Z, Koed K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature, 2005, 434(7035) :864.
  • 10Jazayeri A, Falck J, Lukas C, et al. ATM- and cell cycle-dependent regulation of ATR in response to DNA double strand breaks. Nat Cell Biol, 2006, 8(1) :37.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部